Brokerages Set Colgate-Palmolive Company (NYSE:CL) PT at $89.87

Shares of Colgate-Palmolive Company (NYSE:CL) have earned a consensus recommendation of “Moderate Buy” from the fifteen research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $89.8667.

A number of brokerages recently issued reports on CL. Evercore ISI decreased their price objective on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating on the stock in a research note on Monday, November 3rd. Raymond James Financial decreased their price target on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Citigroup lowered their price target on Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a report on Monday, November 3rd. UBS Group dropped their price objective on Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. Finally, Wells Fargo & Company decreased their target price on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating on the stock in a research report on Monday, November 3rd.

Colgate-Palmolive Stock Down 1.0%

Shares of CL opened at $78.01 on Friday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive has a 12 month low of $74.54 and a 12 month high of $100.18. The firm’s 50 day moving average is $79.18 and its 200-day moving average is $85.26. The stock has a market capitalization of $62.88 billion, a PE ratio of 21.91, a P/E/G ratio of 4.44 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company’s revenue was up 1.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.91 EPS. Equities research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 14th. Investors of record on Friday, October 17th were issued a dividend of $0.52 per share. The ex-dividend date of this dividend was Friday, October 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. Colgate-Palmolive’s payout ratio is 58.26%.

Institutional Trading of Colgate-Palmolive

Hedge funds have recently added to or reduced their stakes in the stock. Grimes & Company Inc. increased its position in Colgate-Palmolive by 1.0% during the 2nd quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock valued at $1,136,000 after purchasing an additional 118 shares during the period. RFG Advisory LLC boosted its stake in shares of Colgate-Palmolive by 1.4% in the 2nd quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after purchasing an additional 123 shares during the last quarter. Tiemann Investment Advisors LLC increased its position in shares of Colgate-Palmolive by 2.1% during the second quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock worth $553,000 after buying an additional 125 shares during the period. Redhawk Wealth Advisors Inc. raised its stake in Colgate-Palmolive by 2.4% during the second quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock worth $497,000 after buying an additional 129 shares during the last quarter. Finally, Westside Investment Management Inc. lifted its holdings in Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after buying an additional 130 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.